Academic Journals Database
Disseminating quality controlled scientific knowledge

Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C Coinfection in a Patient with Human Immunodeficiency Virus Infection

Author(s): Figen Kaptan | Nesrin Türker | Bahar Örmen | Sibel El | Can Hüseyin Hekimoğlu | İlknur Vardar | Serap Ura | Aslı Gamze Şener | Nejat Ali Coşkun

Journal: Klimik Journal
ISSN 1301-143X

Volume: 24;
Issue: 02;
Start page: 122;
Date: 2011;
Original page

Keywords: HIV | HCV antibodies | coinfection | pegylated interferon alpha 2a | ribavirin.

Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection is seen frequently due to similar routes of transmission. In coinfected patients, progression of chronic hepatitis C (CHC) infection is accelerated. In this study, a 44-year old male patient with HIV/HCV (genotype 1b) coinfection is evaluated. For the treatment of CHC, pegylated interferon alpha 2a 180 mg per week and ribavirin 1000 mg/day were used for 48 weeks and sustained virologic response was achieved. During the course of CHC treatment no adverse effect was seen.
Why do you need a reservation system?      Affiliate Program